| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ibrutinib in der Behandlung von Patienten mit chronisch-lymphatischer Leukämie - Ibrutinib in the treatment of patients with chronic lymphocytic leukemia
|
Flammiger, A.
|
|
2015
|
21 |
8 |
p. 732-733
|
article
|
| 2 |
Kostenexplosion in der medikamentösen Therapie onkologischer Erkrankungen - Runaway costs of drug-based treatment of cancer
|
Ludwig, W.-D.
|
|
2015
|
21 |
8 |
p. 708-716
|
article
|
| 3 |
Kosten-Nutzen-Bewertung des IQWiG - Evaluation of the costs-benefit ratio by the IQWiG
|
Guntinas-Lichius, O.
|
|
2015
|
21 |
8 |
p. 691-700
|
article
|
| 4 |
Onkologie und Versorgung in Fach- und Publikumsmedien
|
Gaisser, A.
|
|
2015
|
21 |
8 |
p. 734-738
|
article
|
| 5 |
„Permanentes Ausgabenfieber führt zu finanzieller Atemnot“ - “Permanent spending fever causes financial breathlessness”
|
Oberender (†), P.
|
|
2015
|
21 |
8 |
p. 674-676
|
article
|
| 6 |
Priorisierung oder Rationierung in der Onkologie? - Prioritization or rationing in oncology?
|
Knoepffler, N.
|
|
2015
|
21 |
8 |
p. 717-723
|
article
|
| 7 |
Prävention und Management kardiovaskulärer Erkrankungen mit Nilotinib - Prevention and management of cardiovascular diseases during treatment with the tyrosine kinase inhibitor nilotinib
|
Kiani, A.
|
|
2015
|
21 |
8 |
p. 724-731
|
article
|
| 8 |
Ressourcenallokation in der Onkologie - Resource allocation in oncology
|
Gundermann, C.
|
|
2015
|
21 |
8 |
p. 677-683
|
article
|
| 9 |
Urothelkarzinom - Urothelial carcinoma
|
Fink, S.E.K.
|
|
2015
|
21 |
8 |
p. 739-748
|
article
|
| 10 |
Wachstumsmarkt Onkologie - Growth market oncology
|
Oberender, P.
|
|
2015
|
21 |
8 |
p. 701-707
|
article
|
| 11 |
Zusatzentgelte und NUB – Bedeutung in der Onkologie - Co-payment structures and innovation reimbursement structures—their relevance for oncology
|
Thalheimer, M.
|
|
2015
|
21 |
8 |
p. 684-690
|
article
|
Journal description